Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

58364 1487845784HCLSReviewSingaporeFeb2017.pdf
Energy Boardroom

SMC recommends six products but rejects two for diabetes

11.03.2014 / Scripintelligence

The SMC noted that: "The availability of afatinib will provide clinicians and patients with an additional TKI for use in the treatment of EGFR mutation positive NSCLC."

Cover_HCLS_Singapore LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: